Roberto Rodrigues Ferreira Selected Research

Roberto Rodrigues Ferreira Research Topics

6	Chagas Disease (American Trypanosomiasis) 11/2023 - 05/2016
3	Fibrosis (Cirrhosis) 11/2023 - 01/2019
3	Infections 01/2022 - 05/2016
2	Inflammation (Inflammations) 01/2024 - 11/2023
2	Heart Diseases (Heart Disease) 01/2022 - 01/2019
1	Neoplasms (Cancer) 01/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2024
1	Virus Diseases (Viral Diseases) 01/2024
1	Thyroid Diseases (Thyroid Disease) 01/2024
1	Hypoxia (Hypoxemia) 01/2022
1	Sinus Arrhythmia 01/2019
1	Communicable Diseases (Infectious Diseases) 01/2018

3	CytokinesIBA 01/2022 - 01/2018
3	Transforming Growth Factor beta (TGF-beta)IBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2016
2	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2021
2	CollagenIBA 11/2023 - 05/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 01/2022
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 01/2018
2	Therapeutic UsesIBA 01/2022 - 01/2019
2	Codon (Codons)IBA 01/2021 - 01/2018
1	Selenoproteins (Selenoprotein)IBA 01/2024
1	SeleniumIBA 01/2024
1	AntioxidantsIBA 01/2024
1	Bevacizumab (Avastin)FDA Link 11/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2023
1	Protein Kinases (Protein Kinase)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Connexin 43 (Connexin43)IBA 01/2019
1	4- (4- (3- (pyridin- 2- yl)- 1H- pyrazol- 4- yl)pyridin- 2- yl)- N- (tetrahydro- 2H- pyran- 4- yl)benzamideIBA 01/2019
1	Fibronectins (Fibronectin)IBA 05/2016

2	Therapeutics 01/2022 - 01/2019